Tapewire

OTC · USD

VYCO

VYCOR MEDICAL INC

Export transactions ↓
Tapewire entity
8497
SEC CIK
0001424768
Parsed reports
85

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2022 Filed Oct 18, 2022 20:47 UTC OtherCommon stock 535,714 $0.11 $56,785.68
Disclosure

SEC source: 0001493152-22-028659 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,340,520

F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2022

Read SEC document
June 30, 2022 Filed Jul 13, 2022 10:07 UTC OtherCommon stock 535,714 $0.14 $73,928.53
Disclosure

SEC source: 0001493152-22-019121 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,804,806

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2022

Read SEC document
March 31, 2022 Filed Apr 13, 2022 21:20 UTC OtherCommon stock 535,714 $0.09 $45,535.69
Disclosure

SEC source: 0001493152-22-009848 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,269,092

F1 · kind: Shares issued on account of accrued consultancy fees as of March 31, 2022

Read SEC document
September 30, 2021 Filed Oct 8, 2021 17:19 UTC OtherCommon stock 535,714 $0.14 $77,142.82
Disclosure

SEC source: 0001493152-21-025019 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,197,664

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2021

Read SEC document
September 30, 2021 Filed Jan 18, 2022 11:15 UTC OtherCommon stock 535,714 $0.10 $51,964.26
Disclosure

SEC source: 0001493152-22-001390 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,733,378

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2021

Read SEC document
June 30, 2021 Filed Jul 20, 2021 16:12 UTC OtherCommon stock 535,714 $0.14 $74,999.96
Disclosure

SEC source: 0001493152-21-017286 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,661,950

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2021

Read SEC document
April 01, 2021 Filed Apr 8, 2021 06:32 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33.333 $0.21 $7.00
Disclosure

SEC source: 0001493152-21-008263 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 625,449

Read SEC document
March 31, 2021 Filed Apr 8, 2021 10:34 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-21-008265 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 594,985

Read SEC document
March 31, 2021 Filed Apr 8, 2021 10:33 UTC OtherCommon stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-21-008264 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,126,236

F1 · kind: Shares issued on account of accrued consultancy fees as of March 31, 2021.

Read SEC document
January 01, 2021 Filed Jan 11, 2021 15:26 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33.333 $0.21 $7.00
Disclosure

SEC source: 0001493152-21-000737 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 592,116

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2020 Filed Jan 11, 2021 20:22 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-21-000735 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 561,652

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2020 Filed Jan 11, 2021 20:19 UTC OtherCommon stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-21-000733 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,590,522

F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2020.

Read SEC document
October 01, 2020 Filed Oct 6, 2020 17:20 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-019046 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 558,783

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
September 30, 2020 Filed Oct 6, 2020 21:18 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-019042 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 528,319

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
September 30, 2020 Filed Oct 6, 2020 21:18 UTC OtherCommon Stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-20-019041 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,054,808

F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2020.

Read SEC document
July 01, 2020 Filed Jul 7, 2020 21:37 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-012775 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 525,450

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
June 30, 2020 Filed Jul 8, 2020 01:36 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-012774 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 494,986

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
June 30, 2020 Filed Jul 8, 2020 01:35 UTC OtherCommon Stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-20-012773 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,519,094

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2020.

Read SEC document
June 30, 2020 Filed Jul 8, 2020 01:34 UTC OtherVycor Medical Inc. Common Stock Par Value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-012772 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,949

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 06:16 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-005944 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 492,117

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2020 Filed Apr 7, 2020 10:15 UTC OtherCommon Stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-20-005942 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,983,381

F1 · kind: Shares issued on account of accrued consultancy fees as of March 31, 2020.

Read SEC document
March 31, 2020 Filed Apr 7, 2020 10:15 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-005943 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 461,653

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2020 Filed Apr 7, 2020 10:13 UTC OtherVycor Medical Inc. Common Stock Par Value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-005941 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 473,616

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
January 01, 2020 Filed Jan 7, 2020 06:07 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-000287 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 458,784

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2019 Filed Jan 7, 2020 11:06 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-000285 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,320

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2019 Filed Jan 7, 2020 11:04 UTC OtherCommon Stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-20-000283 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,447,667

F1 · kind: Shares issued on account of accrued consultancy fees as of December 31, 2019.

Read SEC document
December 31, 2019 Filed Jan 7, 2020 11:02 UTC OtherVycor Medical Inc. Common Stock Par Value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-20-000281 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 440,283

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
October 01, 2019 Filed Oct 9, 2019 14:50 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-015294 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 425,451

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
September 30, 2019 Filed Oct 9, 2019 18:53 UTC OtherCommon Stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-19-015299 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,911,952

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2019.

Read SEC document
September 30, 2019 Filed Oct 9, 2019 18:52 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-015298 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 394,987

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
September 30, 2019 Filed Oct 9, 2019 18:51 UTC OtherVycor Medical Inc. Common Stock Par Value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-015296 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,950

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
July 01, 2019 Filed Jul 2, 2019 16:41 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-010161 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 392,118

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
June 30, 2019 Filed Jul 2, 2019 20:38 UTC OtherVycor Medical Inc. Common Stock Par Value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-010158 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,617

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer,however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
June 30, 2019 Filed Jul 2, 2019 20:37 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-010156 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,654

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
June 30, 2019 Filed Jul 2, 2019 20:35 UTC OtherCommon Stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-19-010154 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,376,238

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2019.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 15:25 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-004810 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 358,785

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2019 Filed Apr 3, 2019 19:28 UTC OtherVycor Medical Inc. Common Stock Par Value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-004815 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,284

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer,however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2019 Filed Apr 3, 2019 19:28 UTC OtherCommon Stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-19-004816 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,840,524

F1 · kind: Shares issued on account of accrued consultancy fees as of March 31, 2019.

Read SEC document
March 31, 2019 Filed Apr 3, 2019 19:31 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-004818 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,321

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
January 01, 2019 Filed Jan 8, 2019 13:51 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-000307 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,452

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2018 Filed Jan 8, 2019 18:43 UTC OtherVycor Medical Inc.Common Stock Par Value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-000302 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,951

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer,however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2018 Filed Jan 8, 2019 18:49 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-19-000306 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,988

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2018 Filed Jan 8, 2019 18:42 UTC OtherCommon Stock 535,714 $0.21 $112,499.94
Disclosure

SEC source: 0001493152-19-000301 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,304,810

F1 · kind: Shares issued on account of accrued consultancy fees as of December, 2018.

Read SEC document
October 01, 2018 Filed Oct 23, 2018 09:29 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 24,138 $0.29 $7,000.02
Disclosure

SEC source: 0001493152-18-014775 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,119

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
September 30, 2018 Filed Oct 23, 2018 13:28 UTC OtherCommon Stock 387,931 $0.29 $112,499.99
Disclosure

SEC source: 0001493152-18-014774 · ownership.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,769,096

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2018.

Read SEC document
September 30, 2018 Filed Oct 23, 2018 13:27 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 24,138 $0.29 $7,000.02
Disclosure

SEC source: 0001493152-18-014772 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,618

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
September 30, 2018 Filed Oct 23, 2018 13:27 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 24,138 $0.29 $7,000.02
Disclosure

SEC source: 0001493152-18-014771 · ownership.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,655

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
July 01, 2018 Filed Jul 10, 2018 06:03 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 21,212 $0.33 $6,999.96
Disclosure

SEC source: 0001493152-18-009840 · ownership.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,981

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
June 30, 2018 Filed Jul 10, 2018 10:10 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 21,212 $0.33 $6,999.96
Disclosure

SEC source: 0001493152-18-009843 · ownership.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,480

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
June 30, 2018 Filed Jul 10, 2018 10:10 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 21,212 $0.33 $6,999.96
Disclosure

SEC source: 0001493152-18-009842 · form4.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,517

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.